Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office

Generated: March 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078686

« Back to Dashboard

NDA 078686 describes ADENOSINE, which is a drug marketed by Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Mylan Asi, and is included in twenty NDAs. It is available from sixteen suppliers. Additional details are available on the ADENOSINE profile page.

The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 078686
Applicant:Mylan Labs Ltd
Formulation / Manufacturing:see details
Pharmacology for NDA: 078686
Mechanism of ActionAdenosine Receptor Agonists
Medical Subject Heading (MeSH) Categories for 078686
Suppliers and Packaging for NDA: 078686
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADENOSINE adenosine INJECTABLE;INJECTION 078686 ANDA Sagent Pharmaceuticals 25021-301 N 25021-301-02
ADENOSINE adenosine INJECTABLE;INJECTION 078686 ANDA Sagent Pharmaceuticals 25021-301 N 25021-301-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3MG/ML
Approval Date:May 13, 2009TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.